Real-time AR navigation with dynamic tracking for millimeter-level pulmonary nodule localization: A randomized clinical trial.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 42520806.
- Also identified by DOI 10.1016/j.xcrm.2026.102942.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Precise localization of small pulmonary nodules is crucial for surgery. Augmented reality (AR) navigation provides real-time guidance, potentially improving localization efficiency. This open-label randomized controlled trial compares AR-guided localization with conventional computed tomography (CT)-guided localization in 168 participants with peripheral pulmonary nodules ≤2 cm. The primary outcome is localization accuracy; secondary outcomes are success rate, procedural time, radiation dose, insertion attempts, and complications. In the intention-to-treat population, the AR group shows significantly lower localization error than the CT group (4.50 ± 3.07 vs. 6.50 ± 3.54 mm), with shorter procedural time, lower radiation exposure, and fewer needle adjustments. Both groups show high success rates and similar complication rates, with no severe adverse events. AR-guided localization provides noninferior accuracy while reducing radiation exposure and procedural time, supporting an efficient alternative to CT guidance. The trial is registered at www.clinicaltrials.gov (NCT06335563).